Search academic texts

Information × Registration Number 0307U001014, 0105U000556 , R & D reports Title Development of treatment taktics in primary patients with refractory malignant lymphomas, taking into account the prognosis factors popup.stage_title Розробити комплексні методи лікування хворих на рефрактерні форми дрібноклітинних та великоклітинних неходжкінських лімфом, лімфогранулематозу з урахуванням факторів прогнозу Head Sivkovich S., Registration Date 04-01-2007 Organization Institute of Oncology AMS of Ukraine popup.description2 Object of study - patients with refractory forms of malignant limphomas (ML). Objective of study - to develop complex methods of the treatment of patients with refractory forms ML with taking into account predictive factors. Methods of study - morphological, imunohistochemical, clinical, statistical. In the treatment of patients with refractory forms of non-Hodgkin's lymphomas (NHL) use of multicomponent schedules of chemotherapy adding paclitaxel, irinotecan, hemcitabine, oxaliplatin, rytuximab allows achieve complete remission in 96% of cases. Substitution of doxorubicine for mytoxantron or idarubicin in schedules of chemotherapy of aged patients with NHL allows avoid cardiotoxic complications. In the treatment of refractory forms of lymphogranulematosis multicomponent schedules of chemotherapy are preferable while radiotherapy is adjuvant. Field of use - oncology5635 Product Description popup.authors popup.nrat_date 2020-04-02 Close